BIOTU

Biotech Acquisition Company

Price

return (12m)

p/e

36.27

p/bv

1.34

DIVIDEND YIELD

0.00%

BIOTU price

Biotech Acquisition

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment BIOTU

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals BIOTU

Valuation

P/E

36.27

Sector -139.65

Industry 10.95

P/BV

1.34

Sector -10.05

Industry 1.68

P/Revenue (PSR)

Sector -11.25

Industry 1.62

EV/EBITDA

Sector -1,043.99

Industry 10.56

EV/EBIT

Sector -3,664,431,136.53

Industry 9.05

P/EBITDA

43.14

Sector -110.70

Industry 7.85

P/EBIT

43.14

Sector -127.46

Industry 5.61

P/Total Assets

1.26

Sector 0.14

Industry 0.49

P/Net Current Assets

Sector -10.46

Industry -0.66

P/Working Capital

Sector -

Industry -3.49

EPS

0.28

Sector -9,547.75

Industry 13.05

BVPS

7.59

Sector -8,481.76

Industry 68.27

Efficiency

Gross Margin

0.00%

Sector 0.92%

Industry 20.69%

EBITDA Margin

Sector -292.19%

Industry 15.51%

EBIT Margin

0.00%

Sector -7.22%

Industry 6.87%

Net Profit Margins

0.00%

Sector -2.47%

Industry 14.88%

Asset Turnover

0.00

Sector 0.01

Industry 0.08

Profitability

ROE

3.68%

Sector -1,328.29%

Industry 17.28%

ROA

3.47%

Sector -8.22%

Industry 4.89%

ROIC

Sector -12.38%

Industry 2.05%

Dividends

Dividend yield

0.00%

Sector 0.26%

Industry 1.91%

Payout

0.00%

Sector 5.25%

Industry 18.09%

Debt

Current Ratio

Sector -

Industry 0.86

Net Debt / EBITDA

Sector -159.63

Industry -15.82

Net Debt / EBIT

Sector -3,461,725,776.83

Industry -22.01

Net Debt / Equity

Sector -0.82

Industry -0.55

Gross Debt / Equity

Sector -0.24

Industry 0.04

Equity/Assets

0.94

Sector -0.03

Industry 0.27

Liabilities/Assets

0.94

Sector 0.36

Industry 0.73

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals BIOTU

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Biotech Acquisition ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$6.91

Upside

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BIOTU Biotech Acquisition Company	$0.00	-	0.00%	36.27	1.34	3.68%	0.00%
HRZN Horizon Technology Finance Corporation	$4.18	-14.03%	24.83%	56.28	0.68	1.21%	-100.00%
ARCC Ares Capital Corporation	$18.39	1.62%	10.19%	14.09	0.97	6.91%	55.46%
GAIN Gladstone Investment Corporation	$14.83	13.75%	6.30%	3.67	0.94	25.53%	100.00%
BKCC BlackRock Capital Investment Corporation	$0.00	-	10.81%	9.46	0.86	9.04%	80.08%
RILYT B. Riley Financial Inc.	$20.35	74.81%	7.26%	1.35	3.14	231.65%	41.15%
WHF WhiteHorse Finance Inc.	$7.49	24.43%	13.52%	21.31	0.66	3.09%	16.60%
BEN Franklin Resources Inc.	$30.85	45.36%	4.24%	14.41	1.24	8.62%	11.94%
FDUS Fidus Investment Corporation	$18.54	1.51%	11.49%	9.45	0.99	10.47%	67.26%
SLRC SLR Investment Corp.	$11.17	-14.62%	12.55%	8.49	0.64	7.51%	-100.00%
MSCI MSCI Inc.	$560.83	6.40%	1.40%	30.61	-15.46	-50.49%	40.74%
BANX StoneCastle Financial Corp.	$19.64	-0.24%	10.77%	4.03	0.81	20.19%	85.49%
GLAD Gladstone Capital Corporation	$18.52	7.99%	9.58%	8.81	0.87	9.91%	65.72%
VRTS Virtus Investment Partners Inc.	$120.20	-30.40%	7.79%	6.86	0.87	12.66%	14.52%
TRIN Trinity Capital Inc.	$15.86	21.96%	12.50%	10.44	1.16	11.16%	58.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BIOTU - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Biotech Acquisition

Biotech Acquisition Company

Average Investor10 user rating

4.0 (1 people)

United States

6 years

Founded: 2020

2021

Time since IPO - 5 years

-

Employees

Biotech Acquisition Company (United States) is listed on the Nasdaq and has a market capitalization of $291.53 million, with shareholders equity totaling $218.17 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Biotech Acquisition Company reported $- in revenue, generating net income of $8.04 million.

Key financial metrics include a P/E ratio of 36.27, a price-to-book (P/B) ratio of 1.34, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BIOTU.

Market cap

$291.53 million

Net worth

$218.17 million

$218,174,025.00

Assets

$231.39 million

$231,389,235.00

Total Shares Outstanding

28.75 million

28,750,000

Average Daily Trading Volume

$938.68

Sector

Financial

Industry

Capital Markets

BIOTU

BIOTU revenue and profits

Financial Results BIOTU

DRAG THE FRAME TO SEE MORE DATA

BIOTU cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BRK-A - Berkshire Hathaway

$795,800.00 7,80% (12M)

P/E

13.28

0.00%

ROE

11.45%

P/BV

1.52

BRK-B - Berkshire Hathaway

$530.81 7,80% (12M)

P/E

13.28

0.00%

ROE

11.46%

P/BV

1.52

ING - ING Group

$32.94 43,14% (12M)

P/E

3.26

3.98%

ROE

23.39%

P/BV

0.76

JPM - JPMorgan

$336.12 15,71% (12M)

P/E

14.02

1.77%

ROE

17.37%

P/BV

2.44

LYG - Lloyds Banking Group

$5.42 25,50% (12M)

P/E

3.45

3.97%

ROE

12.34%

P/BV

0.43

DB - Deutsche Bank

$31.82 --2,72% (12M)

P/E

4.65

2.65%

ROE

7.85%

P/BV

0.36

BCS - Barclays

$22.20 17,25% (12M)

P/E

7.33

2.67%

ROE

5.81%

P/BV

0.43

SNEX - StoneX Group

$56.92 27,73% (12M)

P/E

12.72

0.00%

ROE

18.53%

P/BV

2.36